- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04637984
The Implementation of PREP2 Algorithm Into Clinical Practice (PRESTO)
September 30, 2025 updated by: Sofia Straudi, University Hospital of Ferrara
The Implementation of PREP2 Algorithms Into Clinical Practice: a Strategy for Improving Rehabilitation Efficiency and Clinical Outcomes After Stroke. A Single-site Randomized Control Trial
Stroke is a worldwide major cause of disability with great social and economic burdens.
The recovery of motor function is crucial for the patient to regain independence and quality of life.
Identifying early predictors of motor recovery and outcomes is useful for planning personalized rehabilitation programs and increasing their efficiency.
However, making predictions using a single clinical assessment is often difficult and a combination of multiple tools is required.
In the last decades, were validated two predictive algorithms for upper limb function and independent walking that can be easily implemented into clinical practice with the aim of increasing knowledge on expected outcome after stroke in patients, families and rehabilitation teams.
This will be the first single-site randomized control trial that will test the implementation of such tools in a rehabilitation setting in Italy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Emilia-Romagna
-
Ferrara, Emilia-Romagna, Italy, 44124
- Department of Neuroscience and Rehabilitation, University Hospital of Ferrara
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 76 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- diagnosis of stroke;
- new upper and/or lower limb weakness.
Exclusion Criteria:
- cerebellar or bilateral stroke;
- contraindication to TMS;
- cognitive or communication impairment precluding informed consent;
- assisted walking prior to admission;
- severe medical conditions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Implementation Group
Predictions will be provided to the rehabilitation team and discussed with the patient and their family.
Patients will receive a multidisciplinary rehabilitation according to their individual needs.
|
A) PREP2.
It combines clinical measures and neurological biomarkers in the initial days after stroke: 1) SAFE score (day 3), which is the sum of shoulder abduction and finger extension strength in the paretic upper limb using the Medical Research Council (MRC); 2) NIH Stroke Scale (day 3); 3) transcranial magnetic stimulation (day 3-7) to determine the presence of MEPs in the paretic arm.
According with the aforementioned measures, 4 categories of upper limb recovery will be identified: EXCELLENT, GOOD, LIMITED and POOR.
|
|
No Intervention: Control Group
This group will not received any information on the PREP2
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rehabilitation LOS (days)
Time Frame: Hospital discharge (an average of 3-6 months)
|
Length of stay as measure of rehabilitation efficiency
|
Hospital discharge (an average of 3-6 months)
|
|
Change in Functional International Measure between two time points
Time Frame: Baseline, hospital discharge (an average of 3-6 months)
|
Measure of efficiency of rehabilitation.
Assess a patient's level of disability as well as change in patient status in response to rehabilitation.
|
Baseline, hospital discharge (an average of 3-6 months)
|
|
Change in Rehabilitation Complexity Scale between two time points
Time Frame: Baseline, hospital discharge (an average of 3-6 months)
|
Measure of the complexity of rehabilitation needs and/or interventions.
|
Baseline, hospital discharge (an average of 3-6 months)
|
|
Change in Rehabilitation strategies between two time points
Time Frame: Baseline, week 4
|
Will be assessed tracking: therapists confidence about patients' recovery (0-5 Likert scale); therapy content; therapy duration.
|
Baseline, week 4
|
|
Change in Action Research Arm Test between three time points
Time Frame: week 4, 12, week 26
|
To assess upper extremity performance (coordination, dexterity and functioning)
|
week 4, 12, week 26
|
|
Change in Fugl-Meyer Assessment between three time points
Time Frame: week 4, 12, week 26
|
To assess the sensorimotor impairment in individuals who have had stroke.
|
week 4, 12, week 26
|
|
Change in Stroke Impact Scale 3.0 between three time points
Time Frame: week 4, 12, week 26
|
To evaluate how stroke has impacted your health and life.
|
week 4, 12, week 26
|
|
Change in Electroencephalography power in beta band between three time points
Time Frame: week 4, week 12, week 26
|
EEG data will be recorded with the aim of characterizing the PREP2 recovery classes.
|
week 4, week 12, week 26
|
|
Change in Electroencephalography power in alpha band between three time points
Time Frame: week 4, week 12, week 26
|
EEG data will be recorded with the aim of characterizing the PREP2 recovery classes.
|
week 4, week 12, week 26
|
|
Change in Kinematic data recordings between three time points
Time Frame: week 4, week 12, week 26
|
Kinematic data of trunk and affected hand will be recorded during subject imitations.
Kinematic data will be recorded with the aim of characterizing the PREP2 recovery classes.
|
week 4, week 12, week 26
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Applicability perception and satisfaction degree of the proposed intervention self-report questionnaire.
Time Frame: week 4
|
Self-report questionnaire using a Visual Analogue Scale (0 - Strongly disagree; 10 - Strongly agree).
Higher score indicates greater satisfaction with the treatment.
|
week 4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 27, 2019
Primary Completion (Actual)
December 20, 2022
Study Completion (Actual)
December 20, 2022
Study Registration Dates
First Submitted
October 29, 2020
First Submitted That Met QC Criteria
November 16, 2020
First Posted (Actual)
November 20, 2020
Study Record Updates
Last Update Posted (Estimated)
October 6, 2025
Last Update Submitted That Met QC Criteria
September 30, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Predict_stroke_outcomes
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
Clinical Trials on PREP2 algorithm
-
University of ArizonaWithdrawn
-
Samuel Lunenfeld Research Institute, Mount Sinai...Completed
-
University of California, San FranciscoEko Devices, Inc.CompletedAortic Valve Stenosis | Mitral Regurgitation | Heart Murmurs | Valvular Heart DiseaseUnited States
-
ResMedCompletedObstructive Sleep Apnea (OSA)Australia
-
ResMedRecruitingObstructive Sleep ApneaAustralia
-
Johann Wolfgang Goethe University HospitalHemoSonics LLCTerminatedHemorrhage | BleedingGermany
-
Ottawa Heart Institute Research CorporationActive, not recruitingMitral RegurgitationCanada
-
University of OxfordUnknownHeart Failure, SystolicUnited Kingdom
-
Columbia UniversityNational Institute of Neurological Disorders and Stroke (NINDS)Not yet recruitingModeling of Recruitment CurvesUnited States
-
Kıvanç AkçaHacettepe UniversityCompleted